Von Eschenbach Slated For Nomination As Permanent FDA Head
This article was originally published in The Tan Sheet
FDA Acting Commissioner and National Cancer Institute Director Andrew von Eschenbach, MD, will likely be nominated by President George W. Bush as permanent agency head, former FDA Associate Commissioner for External Relations Peter Pitts said March 9
You may also be interested in...
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, leaving a legacy that includes restarting discussions on whether a third class of drugs is needed
Plan B comment analysis is being handled by an outside contractor with oversight by FDA's Office of Policy, according to Acting Commissioner Andrew von Eschenbach, MD
National Cancer Institute Director Andrew von Eschenbach, MD, brings extensive scientific expertise and experience working with Congress as the head of a high-profile federal agency to the role of FDA commissioner